Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Taliban halted Pakistan medicine imports in Feb 2026, causing shortages and higher costs despite boosting local production.
Afghanistan’s Taliban-led government has disrupted the country’s medicine supply by ending imports from Pakistan in February 2026, aiming to combat counterfeit drugs and boost domestic production.
The abrupt shift has caused shortages, price hikes, and longer delivery times as suppliers turned to Iran, India, and other nations, increasing transport costs from 6–7% to 25–30%.
While domestic manufacturing has expanded to 600 medicines, high energy costs, limited infrastructure, and reliance on imported raw materials restrict output.
Doctors face challenges adjusting prescriptions, and patients experience higher costs and treatment delays, despite long-term goals of self-sufficiency.
Los talibanes detuvieron las importaciones de medicamentos de Pakistán en febrero de 2026, lo que causó escasez y mayores costos a pesar de impulsar la producción local.